Incidence and Clinicopathological Correlation of Cervical Cancer in a Tertiary Care Center: A 5-year Retrospective Study
Arshdeep Kaur, Amisha Chawla, Mridu Manjari
Clinicopathological profile, Risk factors,Cervical cancer
Citation Information :
Kaur A, Chawla A, Manjari M. Incidence and Clinicopathological Correlation of Cervical Cancer in a Tertiary Care Center: A 5-year Retrospective Study. Curr Trends Diagn Treat 2019; 3 (2):64-67.
Introduction: Cervical carcinoma is the second most common cancer of women in India, with the first being breast carcinoma. In 2018, the age standardized incidence rate in the world was 13.1% and in India was14.7%, with 569,847 new cases and 311,365 deaths in 2018 in the world. Infection by human papillomavirus (HPV) is the most common risk factor for cervical cancer, with more than 99% cases expressing viral sequence. The present study was undertaken to study the incidence, various clinical presentations, and the histological types of cervical carcinoma.
Materials and methods: The study was carried out in a tertiary care center for a period of 5 years (January 2015 to December 2019) on histopathologically diagnosed cases of cervical cancer. A total of 308 cases of cervical carcinoma were studied in this period.
Results: Incidence of cervical cancer in the present study was 2.9%. Maximum number of cases was seen in fifth and sixth decades. The most common clinical presentation was postmenopausal bleeding (78.6%) followed by discharge per vaginam (66.6%). On microscopy, squamous cell carcinoma (SCC)-large-cell nonkeratinizing type was most common (89%) followed by adenocarcinoma (5.5%). Other types were adenosquamous (1.9%) and small cell carcinoma (1.9%), and the least common was SCC-large-cell keratinizing type (1.6%). Of the 308 cases, 164 (53.2%) were in stage II followed by 95 cases (30.2%) in stage I.
Conclusion: In conclusion, the current study stressed the fact that as a majority of Indian women are diagnosed at later stages of cervical cancer rather than in its early treatable stages, so there is a need for strengthening and proper implementation of screening programs. Keeping in mind the incidence, the knowledge of vaccination against HPV for prevention of carcinoma cervix should also be followed.
Gco.iarc.fr. 2020. Cancer Today. [online] Available at: http://gco.iarc.fr/today/online-analysis.
Raju K, Raghuveer CV, Sheela SR. Clinico pathological correlation of invasive squamous cell carcinoma of uterine cervix: a cross sectional study. Biomed Res Ther 6(11):3443–3451. DOI: 10.15419/bmrat.v6i11.573.
Dikshit R, Gupta PC, Ramasundarahettige C, et al. Cancer mortality in India: a nationally representative survey. Lancet 2012;379(9828): 1807–1816. DOI: 10.1016/S0140-6736(12)60358-4.
Wang T, Chen B, Yang Y, et al. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases. Hum Pathol 2001;32(5): 479–486. DOI: 10.1053/hupa.2001.24324.
Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003;16(1):1–17. DOI: 10.1128/cmr.16.1.1-17.2003.
Human papillomavirus (HPV) and cervical cancer [Internet]. Who.int.2020. Available from https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer.
Gundrajakuppam L, Vissa S, Nandam MR, et al. Clinic pathological correlation of cervical carcinoma by pap smear. J Biosci Tech 2011;2:439–445.
Brisson M, Kim JJ, Canfell K, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet 2020;395(10224):575–590. DOI: 10.1016/S0140-6736(20)30068-4.
Park KJ, Soslow RA. Current concepts in cervical pathology. Arch Pathol Lab Med 2009;133(5):729–738. DOI: 10.1043/1543-2165-133.5.729.
Kumari A, Pankaj S, Choudhary V, et al. Retrospective analysis of patients of cervical cancer a tertiary center in Bihar. Indian J Cancer 2018;55(1):70–73. DOI: 10.4103/ijc.IJC_482_17.
Jain DK, Shukla P, Gupta V. Clinicopathological survey of carcinoma uterine cervix in patients attending tertiary care hospital of central Uttar Pradesh. IJRPM 2019;3(2):14–17.
Patil N, Deshmukh V, Rathid A, et al. Clinico Pathological correlation of cervical carcinoma: a tertiary hospital-based study int. J Sci Stud 2019;6(10):1–4.
Rana MK, Singh K, Mahajan MK, et al. Clinicopathological profile of cervical carcinoma: an experience of tertiary care cancer centre. Asian Pac J Cancer Care 2019;4(3):83–86. DOI: 10.31557/apjcc.2019.4.3.83-86.
Lakshmi V, Prakash HM, Jyothi BL, et al. Retrospective histopathological analysis of cervical cancer: our experience. Aerchives of Cytology and Histopathology Research 2016;1(1):28–31.
Gupta M, Basavaraj PK. Histopathological spectrum of premalignant and malignant lesions of uterine cervix. national journal of laboratory medicine. 2018;7(1):PO19–PO26.